PRELUDE CAPITAL MANAGEMENT, LLC - BIONTECH SE ownership

BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 150 filers reported holding BIONTECH SE in Q3 2020. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of BIONTECH SE
ValueSharesWeighting
Q2 2022$526,000
-14.9%
3,525
-2.8%
0.02%
-16.7%
Q1 2022$618,000
-33.9%
3,625
-0.1%
0.02%
-25.0%
Q4 2021$935,000
-47.6%
3,628
-44.5%
0.02%
-46.7%
Q3 2021$1,783,000
+67.7%
6,532
+37.5%
0.04%
+40.6%
Q2 2021$1,063,000
+190.4%
4,750
+41.8%
0.03%
+255.6%
Q1 2021$366,000
+8.3%
3,350
-19.3%
0.01%0.0%
Q4 2020$338,000
+17.8%
4,1500.0%0.01%
-35.7%
Q3 2020$287,000
+135.2%
4,150
+126.4%
0.01%
+100.0%
Q2 2020$122,0001,8330.01%
Other shareholders
BIONTECH SE shareholders Q3 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 148,674$16,151,94319.26%
Quinn Opportunity Partners LLC 659,383$71,635,3699.22%
Systrade AG 50,000$5,432,0004.70%
Crocodile Capital Partners GmbH 29,586$3,214,2233.03%
ALTRINSIC GLOBAL ADVISORS LLC 700,421$76,093,7372.94%
Temasek Holdings (Private) Ltd 4,518,080$490,844,2112.92%
PARUS FINANCE (UK) Ltd 25,662$2,787,9201.74%
FLOSSBACH VON STORCH AG 3,513,215$381,675,6781.68%
AtonRa Partners 4,707$511,3681.07%
Baader Bank Aktiengesellschaft 135,093$14,617,4560.99%
View complete list of BIONTECH SE shareholders